PharmaZell GmbH:企業の戦略的SWOT分析

◆英語タイトル:PharmaZell GmbH - Strategic SWOT Analysis Review
◆商品コード:DATA904C15908
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PharmaZell GmbH – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

PharmaZell GmbH (PharmaZell) develops and produces generic active pharmaceutical ingredients (API) and intermediates. The company also offers formulation development services. Its major products include generic APIs and amino acids. It provides a wide range of API related services for diverse phases of the drug development process for producers of generic drugs and for originators in the pharmaceutical industry. The development services range from evaluation to registration that includes project management, finished dosage form, process R&D, analytical R&D, pilot scale manufacturing API, pilot scale manufacturing FDF and regulatory documentation. The company has manufacturing facilities in Raubling, Germany; Liestal, Switzerland; Gropello, Italy; and Chennai and Visakhapatnam, India. PharmaZell is headquartered in Raubling, Germany.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
PharmaZell GmbH – Key Facts
PharmaZell GmbH – Key Employees
PharmaZell GmbH – Key Employee Biographies
PharmaZell GmbH – Key Operational Employees
PharmaZell GmbH – Major Products and Services
PharmaZell GmbH – History
PharmaZell GmbH – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
PharmaZell GmbH – Business Description
PharmaZell GmbH – SWOT Analysis
SWOT Analysis – Overview
PharmaZell GmbH – Strengths
PharmaZell GmbH – Weaknesses
PharmaZell GmbH – Opportunities
PharmaZell GmbH – Threats
PharmaZell GmbH – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
PharmaZell GmbH, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
PharmaZell GmbH, Key Facts
PharmaZell GmbH, Key Employees
PharmaZell GmbH, Key Employee Biographies
PharmaZell GmbH, Key Operational Employees
PharmaZell GmbH, Major Products and Services
PharmaZell GmbH, History
PharmaZell GmbH, Subsidiaries
PharmaZell GmbH, Key Competitors
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
PharmaZell GmbH, Recent Deals Summary

List of Figures
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
PharmaZell GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[PharmaZell GmbH:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Texas Health Resources, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Texas Health Resources, Inc. Me …
  • Beximco Pharmaceuticals Ltd. (BXPHARMA):企業の財務及び戦略的SWOT分析
    Summary Beximco Pharmaceuticals Ltd. (BPL), a subsidiary of Beximco Group is a pharmaceutical company that manufactures generic products. The company manufactures and exports pharmaceutical formulations and active pharmaceutical ingredients. Its product range including analgesics, antipyretics, anti …
  • NCC Limited (NCC):企業のM&A・提携動向(発電分野)
    Summary NCC Limited (NCC), formerly Nagarjuna Construction Company Limited, is an Indian heavy construction contractor. The company specializes in diversified businesses such as construction of flyovers, airport terminals and ports, highways, industrial, water supply and environment projects, housin …
  • Chunghwa Post Co., Ltd.:企業の戦略・SWOT・財務分析
    Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vp Plc (VP.):企業財務及び戦略的SWOT分析
    Summary Vp Plc (VPP) is an infrastructure service provider that provides equipment rental and related services. The company operates through its business divisions such as Airpac Bukom, Groundforce, Hire Station, Torrent Trackside, UK Forks and TPA. Its Airpac Bukom division provides performance com …
  • Weidenhammer Packungen GmbH and Co KG(紙・包装分野):企業概要及びSWOT分析
    Product Synopsis Canadean's "Weidenhammer Packungen GmbH and Co KG: Paper and Packaging - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, busi …
  • Ithaca Energy Inc. (IAE):企業のM&A・提携動向(石油・ガス分野)
    Summary Ithaca Energy Inc. (Ithaca) is an oil and gas company, which explores for, develops, and produces oil and gas in the North Sea. It focuses on the appraisal and development of undeveloped discoveries and the exploitation of its existing UK producing asset portfolio. The company has a portfoli …
  • Interconexion Electrica S.A. E.S.P. (ISA):企業のM&A・提携動向(エネルギー分野)
    Summary Interconexion Electrica S.A. E.S.P. (ISA) is an energy distributor. The company through its subsidiaries and affiliates engages in the design, construction, administration and operation of linear infrastructure systems of electricity and telecommunications connectivity. It is involved in ope …
  • Northeastern Rural Electric Membership Corp:企業の戦略的SWOT分析
    Northeastern Rural Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Harley-Davidson Inc (HOG):企業の財務・戦略的SWOT分析
    Harley-Davidson Inc (HOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gevo, Inc. (GEVO):企業概要、財務及び戦略的SWOT分析
    Summary Gevo, Inc. (Gevo) is a biotechnology company. The company develops biofuels such as isobutanol, solvents and coatings, materials, plastics, fibers, biojet blendstock and specialty fuels. It offers services such as metabolic engineering and process engineering. Gevo’s GIFT platform is designe …
  • CLP Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CLP Holdings Limited Mergers an …
  • Blueprint Medicines Corp (BPMC):製薬・医療:M&Aディール及び事業提携情報
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Clariant Chemicals (India) Limited (CLNINDIA):企業の財務・戦略的SWOT分析
    Clariant Chemicals (India) Limited (CLNINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Mytilineos Holdings S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mytilineos Holdings S.A. Merger …
  • Hansa.net Global Commerce, Inc. (KMC.H):企業の財務及び戦略的SWOT分析
    Summary Hansa.net Global Commerce, Inc. (Hansa.net) is a technology company that offers computer system development and software design services. The company’s services include marketing, software product development, international trade technology and incubator and accelerator services. It offers l …
  • Integrata AG (ITR):企業財務及び戦略的SWOT分析
    Summary Integrata AG (Integrata) is a technology and communication company that provides qualification projects and qualification processes, training logistics and seminars. The company offers open and in-house seminars in the fields of social media and e-learning, personnel and organizational devel …
  • JiangXi ChangJiu Biochemical Industry Co., Ltd. (600228):企業財務及び戦略的SWOT分析
    Summary JiangXi ChangJiu Biochemical Industry Co., Ltd. (ChangJiu Biochemical) formerly Jiangxi Changjiu Chemicals Co., Ltd is a chemical company that manufactures and markets acrylamide crystals, pharm-chemicals, fine chemicals and coal products. The company’s products comprise urea, biological met …
  • AngloGold Ashanti Limited:戦略・SWOT・企業財務分析
    AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report Summary AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kier Group plc (KIE):企業のM&A・提携動向(エネルギー分野)
    Summary Kier Group plc (Kier) is a construction, property and services company, specialized in residential and commercial property development, and infrastructure project investment. The company’s services include construction and civil engineering, support services, property development, and privat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆